MiR-30a inhibits BECN1-mediated autophagy in diabetic cataract

Lu Zhang1,2, Rong Cheng2,3, Yusen Huang2

  • 1Department of Ophthalmology, School of Medicine, Shandong University, Jinan 250012, China.

Oncotarget
|November 5, 2017
PubMed
Abstract

Insights

MicroRNA-30a (miR-30a) inhibits autophagy and apoptosis in human lens epithelial cells (LECs) during diabetic cataract formation by targeting BECN1. This finding offers insights into diabetic cataract pathogenesis.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Cell Biology

Background:

  • Diabetic cataract is a common complication of diabetes mellitus.
  • Lens epithelial cells (LECs) play a crucial role in maintaining lens transparency.
  • Autophagy and apoptosis are cellular processes implicated in cataract formation.

Purpose of the Study:

  • To investigate the role of microRNAs (miRNAs) in regulating autophagy and apoptosis in LECs during diabetic cataract.
  • To identify specific miRNAs involved in the pathogenesis of diabetic cataract.

Main Methods:

  • miRNA microarray and quantitative real-time PCR to profile miRNA expression in LECs from diabetic cataract tissues.
  • In vitro culture of human LECs under high glucose conditions to model diabetic cataract.
  • Western blotting and quantitative real-time PCR to assess autophagy markers (BECN1, LC3B).
  • Flow cytometry to measure the extent of LEC apoptosis.

Main Results:

  • Downregulation of miR-30a was observed in LECs from diabetic cataract tissues.
  • BECN1 was identified as a direct target of miR-30a.
  • miR-30a inhibited high glucose-induced autophagy mediated by BECN1 in LECs.
  • miR-30a reduced the apoptosis ratio of LECs.

Conclusions:

  • miR-30a plays an inhibitory role in autophagy by targeting BECN1 in LECs within the context of human diabetic cataract.
  • These findings highlight miR-30a as a potential therapeutic target for diabetic cataract.

Related Concept Videos